I'd like to know the reason, Dew, why you have not taken a position in ARIA. You seem to follow the thread, and the story.
Is it valuation? Is it the fact that Ponatinib results are still 12-15 months away (at least)? Do you not like what you see with the Ridaforolimus compound? There's got to be a reason. I'm just wondering what it is...